291 related articles for article (PubMed ID: 24529715)
1. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.
Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715
[TBL] [Abstract][Full Text] [Related]
2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
4. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: implications for radiation target volume design.
Olszyna-Serementa M; Socha J; Wierzchowski M; Kępka L
Lung Cancer; 2013 May; 80(2):179-84. PubMed ID: 23395416
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes.
Billiet C; De Ruysscher D; Peeters S; Decaluwé H; Vansteenkiste J; Dooms C; Deroose CM; De Leyn P; Hendrikx M; Bulens P; Le Péchoux C; Mebis J
J Thorac Oncol; 2016 Sep; 11(9):1538-49. PubMed ID: 27374454
[TBL] [Abstract][Full Text] [Related]
7. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
[No Abstract] [Full Text] [Related]
8. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of recurrence patterns after curative resection of stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2314-8. PubMed ID: 23158558
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.
Kelsey CR; Light KL; Marks LB
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1097-105. PubMed ID: 16682136
[TBL] [Abstract][Full Text] [Related]
11. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
13. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
14. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; DeCamp MM
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):353-9. PubMed ID: 20732754
[TBL] [Abstract][Full Text] [Related]
15. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
16. Contralateral mediastinal lymph node micrometastases assessed by video-assisted thoracoscopic surgery in stage I non-small cell left lung cancer.
Anami K; Yamashita S; Yamamoto S; Chujo M; Tokuishi K; Moroga T; Mori H; Kawahara K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):778-82. PubMed ID: 22822105
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
18. Alternative paratracheal lymph node dissection in left-sided hilar lung cancer patients: comparing the number of lymph nodes dissected to the number of lymph nodes dissected in right-sided mediastinal dissections.
Toker A; Tanju S; Ziyade S; Kaya S; Erus S; Ozkan B; Yilmazbayhan D
Eur J Cardiothorac Surg; 2011 Jun; 39(6):974-80. PubMed ID: 21276734
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiotherapy for patients with completely resected pathologic n2 non-small-cell lung cancer: a retrospective analysis.
Mantovani C; Levra NG; Filippi AR; Novello S; Buffoni L; Ragona R; Ricardi U
Clin Lung Cancer; 2013 Mar; 14(2):194-9. PubMed ID: 22885347
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
